Guardion Health Sciences Inc - SIC # 2833 - MEDICINAL CHEMICALS AND BOTANICAL PRODUCTS

Ticker Exchange SIC # Website Latest Ticker
GHSI Nasdaq 2833 http://guardionhealth.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Guardion Health Sciences Inc

Guardion Health Sciences Announces New Viactiv Omega Boost Gel Bites Now Available for Purchase on Amazon - May 26th, 2022 1:00 pm
Guardion Health Sciences Announces Financial Results for the Quarter Ended March 31, 2022 - May 12th, 2022 12:13 pm
Guardion Health Sciences to Present at the Planet MicroCap Showcase 2022 - May 3rd, 2022 7:45 pm
Keynotes, Educational Panels and 88 Companies to Present at the Planet MicroCap Showcase on May 3-5, 2022 at Bally's Hotel & Casino in Las Vegas, NV - Apr 27th, 2022 1:00 pm
Guardion Health Sciences Announces New Viactiv® Omega Boost Gel Bites Now Available for Purchase Via Viactiv® Shopify Store - Apr 11th, 2022 1:17 pm
Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2021 - Apr 1st, 2022 1:03 pm
Guardion Health Sciences to Participate in Fireside Chat at the 34th Annual Roth Conference - Mar 11th, 2022 1:00 pm
Guardion Health Sciences, Inc. Announces Closing of $11 Million Public Offering - Feb 23rd, 2022 9:15 pm
Guardion Health Sciences, Inc. Announces Pricing of $11 Million Public Offering - Feb 18th, 2022 2:00 pm
Guardion Health Sciences, Inc. Announces Proposed Public Offering - Feb 17th, 2022 2:00 pm
Guardion Health Sciences Launches New Viactiv® Omega BOOST™ Passion Fruit Flavored Gel Bites - Feb 14th, 2022 1:00 pm
Guardion Health Sciences Launches New Online Store for Viactiv - Jan 24th, 2022 1:30 pm
Guardion Health Sciences to Present at the H.C. Wainwright Bioconnect 2022 Virtual Conference - Jan 6th, 2022 1:00 pm
Guardion Health Sciences to Wind Down VectorVision Business Operations and Focus on Exploiting VectorVision Intellectual Property - Dec 23rd, 2021 9:05 pm
Guardion Health Sciences Issues Letter to Shareholders - Dec 16th, 2021 1:00 pm
Guardion Health Sciences Appoints Experienced Healthcare Executive Michaela Griggs to its Board of Directors - Dec 9th, 2021 1:30 pm
Guardion Health Sciences to Present at the Benzinga Global Small Cap Conference - Dec 3rd, 2021 1:00 pm
Guardion Health Sciences Announces Financial Results for the Three Months Ended September 30, 2021 - Nov 10th, 2021 1:37 pm
Guardion Health Sciences Announces Corporate Milestones Designed to Strengthen Financial Results and Improve Customer and Investor Engagement - Oct 14th, 2021 12:00 pm
Guardion Health Sciences Stockholders Urged to Vote Their Shares for October 22, 2021 Annual Meeting - Oct 12th, 2021 2:30 pm